Edition:
India

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

7.15USD
1:30am IST
Change (% chg)

$0.27 (+3.92%)
Prev Close
$6.88
Open
$6.86
Day's High
$7.19
Day's Low
$6.80
Volume
29,264
Avg. Vol
55,445
52-wk High
$11.16
52-wk Low
$5.99

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.592
FY 2018 Dec '18 0.00 -0.621
Sep '18 0.00 -0.542
Jun '18 2.38 -0.457
Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 5 0.32 1.60 0.00 0.80
Quarter Ending Dec-19 5 0.36 1.80 0.00 0.90
Year Ending Dec-19 6 1.07 6.40 0.00 3.15
Year Ending Dec-20 6 13.27 79.60 0.00 8.79
Earnings (per share)
Quarter Ending Sep-19 6 -0.49 -0.40 -0.66 -0.63
Quarter Ending Dec-19 6 -0.50 -0.42 -0.70 -0.64
Year Ending Dec-19 6 -2.07 -1.81 -2.58 -2.28
Year Ending Dec-20 6 -1.91 -1.26 -2.24 -2.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -25.30 -13.87 --
EPS (TTM) % -18.30 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.17 3.12 75 --
13 Week -7.90 -10.87 54 --
26 Week -20.83 -31.21 34 --
52 Week -24.73 -29.88 53 --
YTD -8.14 -23.35 38 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.74%
# of Holders: 108
Total Shares Held: 22,714,740
3 Mo. Net Change: 35,445
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 5
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.